Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NLNK

NewLink Genetics (NLNK) Stock Price, News & Analysis

NewLink Genetics logo

About NewLink Genetics Stock (NASDAQ:NLNK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.89
$14.10
52-Week Range
N/A
Volume
N/A
Average Volume
547,540 shs
Market Capitalization
$162.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NLNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NewLink Genetics and its competitors with MarketBeat's FREE daily newsletter.

NLNK Stock News Headlines

Reproduction DNA and Genetics
What Wall Street expects from NewLink Genetics's earnings
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Best DNA Test for 2024
Newlink Technology Inc.
Newlink Technology Inc (9600)
See More Headlines

NLNK Stock Analysis - Frequently Asked Questions

NewLink Genetics Corp (NASDAQ:NLNK) posted its quarterly earnings results on Wednesday, November, 6th. The biotechnology company reported ($0.27) EPS for the quarter, meeting the consensus estimate of ($0.27). The biotechnology company earned $0.25 million during the quarter. NewLink Genetics had a negative trailing twelve-month return on equity of 41.50% and a negative net margin of 4,592.84%.

Based on aggregate information from My MarketBeat watchlists, some other companies that NewLink Genetics investors own include Bristol Myers Squibb (BMY), Inovio Pharmaceuticals (INO), Arbutus Biopharma (ABUS), OPKO Health (OPK), Gilead Sciences (GILD), CSLM Acquisition (SPWR) and Sarepta Therapeutics (SRPT).

Company Calendar

Last Earnings
11/06/2019
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:NLNK
CIK
1126234
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$42.99 million
Net Margins
-4,592.84%
Pretax Margin
N/A
Return on Equity
-41.50%
Return on Assets
-33.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.98
Quick Ratio
7.98

Sales & Book Value

Annual Sales
$940 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.11 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
37,328,000
Free Float
N/A
Market Cap
$162.00 million
Optionable
Not Optionable
Beta
1.17
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:NLNK) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners